Intellectual property protection for the Swiss pharmaceutical industry has been a key sticking point in negotiations on a free trade agreement with India. Now there seems to be a breakthrough in talks after 16 years. What’s changed?
The African Union is finalizing the draft protocol on intellectual property rights to the agreement establishing the African Continental Free Trade Area (AfCFTA).
The clause in the draft free trade agreement text could delay access to affordable, generic versions of patented drugs in India by a minimum of six years, according to documents.
The “TRIPS-Plus” provisions in the India-UK Agreement are a dangerous attempt to increase the power of pharmaceutical companies by placing profits before public health.
MSF and over 50 UK-based civil society organisations and individuals sent this open letter to United Kingdom Prime Minister, urging him to commit that the UK-India Free Trade Agreement will not gut the public health safeguards that are in India’s intellectual property laws.
The GCC deepens economic ties with major Asian partners, signing its second FTA this year, highlighting commitment to investment and economic diversification.
Indonesia is optimistic that negotiations of the Indonesia-Eurasian Economic Union Free Trade Agreement (IEAEU-FTA) can be completed in 2024 following the agreement on the Intellectual Property (IP) chapter.
The action is rooted in the alleged violation of the 1995 Venezuela-UK Bilateral Investment Treaty, marking a significant turn in the multinational’s relationship with the South American nation.
As both countries inch closer to signing the agreement, discussions have focused on contentious parts such as intellectual property rights (IPR), rules of origin and bilateral investment treaties (BIT)